Advertisement
U.S. Markets open in 9 hrs 2 mins
S&P Futures
5,884.25 -2.75 (-0.05%) Dow Futures
43,475.00 -36.00 (-0.08%) Nasdaq Futures
20,366.50 -1.50 (-0.01%) Russell 2000 Futures
2,293.10 -4.60 (-0.20%) Crude Oil
70.89 +0.22 (+0.31%) Gold
2,725.20 +17.70 (+0.65%)
PSNL Oct 2024 7.500 put
OPR - OPR Delayed Price. Currency in USD
Follow
As of 12:08PM EDT. Market open.
| Previous Close | 1.8000 |
| Open | 2.8200 |
| Bid | 1.9000 |
| Ask | 3.7000 |
| Strike | 7.50 |
| Expire Date | 2024-10-18 |
| Day's Range | 2.8200 - 2.8500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 22 |
Simply Wall St.Personalis, Inc. (NASDAQ:PSNL) has caught the attention of institutional investors who hold a sizeable 38% stake
Key Insights Institutions' substantial holdings in Personalis implies that they have significant influence over the...
Business WireESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test
FREMONT, Calif., September 16, 2024--Personalis, Inc. (Nasdaq: PSNL), a leader in MRD testing, announced findings presented this week at the European Society of Medical Oncology Congress (ESMO) Congress 2024 in Barcelona, Spain. Personalis’ NeXT Personal assay was designed to detect and monitor residual and recurrent disease (MRD) in cancer patients by detecting very small traces of circulating tumor DNA (ctDNA) in the blood. It was launched to the clinic in late 2023 and is being co-commerciali
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.